|
ATGP3753-10ug
|
NKMax Bio (ATGen)
|
Integrin beta 4 [28-710 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP3753-50ug
|
NKMax Bio (ATGen)
|
Integrin beta 4 [28-710 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
HY-13574A-1mg
|
MedChemexpress LLC
|
Biricodar [CAS 159997-94-1]
|
|
Cancer-programmed cell death
|
|
|
HY-13574A-5mg
|
MedChemexpress LLC
|
Biricodar [CAS 159997-94-1]
|
|
Cancer-programmed cell death
|
|
|
HY-139330-10mg
|
MedChemexpress LLC
|
MGH-CP1 [CAS 896657-58-2]
|
|
Cancer-programmed cell death
|
|
|
HY-139330-100mg
|
MedChemexpress LLC
|
MGH-CP1 [CAS 896657-58-2]
|
|
Cancer-programmed cell death
|
|
|
HY-139330-25mg
|
MedChemexpress LLC
|
MGH-CP1 [CAS 896657-58-2]
|
|
Cancer-programmed cell death
|
|
|
HY-139330-5mg
|
MedChemexpress LLC
|
MGH-CP1 [CAS 896657-58-2]
|
|
Cancer-programmed cell death
|
|
|
HY-139330-50mg
|
MedChemexpress LLC
|
MGH-CP1 [CAS 896657-58-2]
|
|
Cancer-programmed cell death
|
|
|
HY-R03937-20nmol
|
MedChemexpress LLC
|
mMu -miR-710 mimic
|
|
Cancer-programmed cell death
|
|
|
HY-R03937-5nmol
|
MedChemexpress LLC
|
mMu -miR-710 mimic
|
|
Cancer-programmed cell death
|
|
|
HY-126248-10mg
|
MedChemexpress LLC
|
Tankyrase-IN-2 [CAS 1588870-36-3]
|
|
Cancer-programmed cell death
|
|
|
HY-126248-100mg
|
MedChemexpress LLC
|
Tankyrase-IN-2 [CAS 1588870-36-3]
|
|
Cancer-programmed cell death
|
|
|
HY-126248-25mg
|
MedChemexpress LLC
|
Tankyrase-IN-2 [CAS 1588870-36-3]
|
|
Cancer-programmed cell death
|
|
|
HY-126248-5mg
|
MedChemexpress LLC
|
Tankyrase-IN-2 [CAS 1588870-36-3]
|
|
Cancer-programmed cell death
|
|
|
HY-126248-50mg
|
MedChemexpress LLC
|
Tankyrase-IN-2 [CAS 1588870-36-3]
|
|
Cancer-programmed cell death
|
|
|
HY-126248-1mL
|
MedChemexpress LLC
|
Tankyrase-IN-2 [CAS 1588870-36-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
